Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-06-21
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.54+30,000191,369,6060%+$136,200
M
2018-06-20
ALRNAileron Therapeutics IncApple Tree Partners II LP10%S - Sale$5.30-6,6471,486,4980%-$35,233
DM
2018-06-19
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale+OE$47.56-30,00030,000-50%-$1,426,745
DM
2018-06-19
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale+OE$47.56-30,00030,000-50%-$1,426,745
M
2018-06-19
LXRXLexicon Pharmaceuticals, Inc.Invus Public Equities, L.P.Dir, 10%P - Purchase$13.29+72,97359,804,3010%+$970,045
2018-06-21
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP, GCS - Sale$82.77-1,22614,181-8%-$101,476
D
2018-06-19
LOXOLoxo Oncology, Inc.Burstein JenniferSVP of FinanceS - Sale+OE$176.99-1,7000-100%-$300,888
DM
2018-06-19
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerS - Sale+OE$178.14-3,08212,000-20%-$549,036
DM
2018-06-19
LOXOLoxo Oncology, Inc.Bilenker Joshua H.Pres, CEOS - Sale+OE$178.62-57,000163,707-26%-$10,181,356
D
2018-06-19
PTCTPtc Therapeutics, Inc.Almstead Neil GregoryEVP Research Pharma Ops, TechS - Sale+OE$48.31-20,00022,279-47%-$966,240
D
2018-06-20
ARRYArray Biopharma IncVan Lunsen Gil JDirS - Sale+OE$19.08-21,50019,297-53%-$410,220
D
2018-06-19
ARRYArray Biopharma IncSandor VictorChief Medical OfficerS - Sale+OE$18.76-77,576210,086-27%-$1,455,326
DM
2018-06-19
GALTGalectin Therapeutics IncCallicutt Jack WCFOS - Sale+OE$8.61-226,0001,260-99%-$1,946,021
M
2018-06-19
SYBXSynlogic, Inc.Miller Paul FrancisChief Scientific OfficerS - Sale$9.77-3,00072,135-4%-$29,303
D
2018-06-20
CTLTCatalent, Inc.Fasman Steven LSVP, GCS - Sale+OE$41.78-2,25243,316-5%-$94,089
AM
2018-06-11
BHVNBiohaven Pharmaceutical Holding Co Ltd.Berman RobertChief Medical OfficerS - Sale$36.36-76,692244,000-24%-$2,788,707
D
2018-06-19
ARWRArrowhead Pharmaceuticals, Inc.Myszkowski Kenneth AllenCFOS - Sale+OE$14.01-20,000310,815-6%-$280,200
D
2018-06-18
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$58.19-4,00023,700-14%-$232,760
M
2018-06-15
AMARAmarillo Biosciences IncChen Stephen TPres,COB, CEO, 10%P - Purchase$0.27+3,0005,509,7410%+$800
D
2018-06-18
CHMAChiasma, IncMamluk RoniDirS - Sale+OE$1.46-2,3890-100%-$3,484
2018-06-19
AXSMAxsome Therapeutics, Inc.Pizzie NickCFOP - Purchase$3.10+31,00031,000New+$96,080
2018-06-19
TYMETyme Technologies, Inc.Demurjian MichaelCOO, 10%S - Sale$3.75-18,09926,651,6550%-$67,871
D
2018-06-18
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$4.38+570,7763,757,218+18%+$2,499,999
M
2018-06-18
XNCRXencor IncStafford John S III10%S - Sale$39.90-250,0005,261,348-5%-$9,974,392
2018-06-18
TYMETyme Technologies, Inc.Hoffman SteveCEO, 10%S - Sale$3.75-13,42526,644,5280%-$50,344
M
2018-06-14
GALTGalectin Therapeutics IncCzirr James CDirS - Sale$8.61-151,8602,649,786-5%-$1,306,807
M
2018-06-14
GALTGalectin Therapeutics Inc10X Fund, L.P.10%S - Sale$8.61-151,8602,649,786-5%-$1,306,807
2018-06-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.32+20,000191,339,6060%+$86,300
2018-06-15
ABBVAbbvie Inc.Richmond Timothy J.SVP, HRS - Sale$99.47-17,5880-100%-$1,749,485
D
2018-06-18
SUPNSupernus Pharmaceuticals IncSchwabe Stefan K.F.EVP R, D, CMOS - Sale+OE$54.39-60,0001,967-97%-$3,263,352
D
2018-06-19
ATHXAthersys, Inc / NewLehmann William JrPres, COOS - Sale+OE$2.25-30,000526,684-5%-$67,380
M
2018-06-15
ALRNAileron Therapeutics IncApple Tree Partners II LP10%S - Sale$5.32-9,5321,493,145-1%-$50,743
M
2018-06-13
AMARAmarillo Biosciences IncChen Stephen TPres,COB, CEO, 10%P - Purchase$0.27+2,0005,506,7410%+$540
D
2018-06-18
ENTAEnanta Pharmaceuticals IncAdda NathalieSVP, Chief Medical OfficerS - Sale+OE$114.86-4,1553,600-54%-$477,222
2018-06-15
VSARVersartis, Inc.Westberg PaulSVP, Chief Business OfficerS - Sale$2.30-612225,1240%-$1,408
2018-06-15
VSARVersartis, Inc.Haas KevinVP, Finance, PAOS - Sale$2.30-14378,0750%-$329
D
2018-06-15
BHVNBiohaven Pharmaceutical Holding Co Ltd.Gentile KimberlyVP of OperationsS - Sale+OE$40.02-12,5000-100%-$500,250
2018-06-15
JAZZJazz Pharmaceuticals PlcYoung Matthew P.EVP, CFOS - Sale$176.99-70035,568-2%-$123,893
2018-06-15
NATRNatures Sunshine Products IncWynnefield Partners Small Cap Value LP10%P - Purchase$8.96+4,0102,202,4540%+$35,918
2018-06-18
KERXKeryx Biopharmaceuticals IncCameron Kevin JDirS - Sale$4.98-1,667176,666-1%-$8,302
D
2018-06-18
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$18.66-10,0001,320,271-1%-$186,558
D
2018-06-18
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$18.66-10,0001,320,271-1%-$186,558
M
2018-06-13
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+8,00025,163,2890%+$300
D
2018-06-18
MRKMerck & Co., Inc.Schechter Adam HEVP, Pres-Global Human HealthS - Sale+OE$61.00-134,09462,766-68%-$8,179,945
2018-06-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.34+14,299191,319,6060%+$62,013
2018-06-15
BMRNBiomarin Pharmaceutical IncMueller BrianSVP, Corporate ControllerS - Sale$94.50-2,02113,029-13%-$190,985
D
2018-06-14
BMRNBiomarin Pharmaceutical IncFuchs Henry JPres, Worldwide R, DS - Sale+OE$90.00-31,000155,167-17%-$2,790,085
DM
2018-06-14
ATHXAthersys, Inc / NewHarrington John JExec Vice Pres, CSOS - Sale+OE$2.30-15,000691,820-2%-$34,513
M
2018-06-14
LXRXLexicon Pharmaceuticals, Inc.Invus Public Equities, L.P.Dir, 10%P - Purchase$12.98+45,78459,731,3280%+$594,399
DM
2018-06-14
LOXOLoxo Oncology, Inc.Kunkel Lori AnneDirS - Sale+OE$179.83-39,2320-100%-$7,055,254
2018-06-15
MCRBSeres Therapeutics, Inc.Aunins John G.CTO, EVPS - Sale$8.57-14,279170,206-8%-$122,325
2018-06-14
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$176.53-20025,972-1%-$35,306
2018-06-14
TGTXTg Therapeutics, Inc.Kennedy William JamesDirS - Sale$13.45-25,07160,330-29%-$337,205
2018-06-18
DERMDermira, Inc.Wiggans Thomas GCEO, COBP - Purchase$10.10+11,875172,760+7%+$119,954
D
2018-06-14
AGIOAgios Pharmaceuticals IncFoster-Cheek Kaye IDirS - Sale+OE$93.55-9,0002,200-80%-$841,926
2018-06-15
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$86.65-180,000122,050,8040%-$15,597,720
D
2018-06-15
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$44.31-3,7768,400-31%-$167,326
2018-06-15
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.42+10,000191,305,3070%+$44,200
2018-06-13
VSARVersartis, Inc.Akkaraju SrinivasDirP - Purchase$2.13+53,0182,682,554+2%+$112,928
D
2018-06-15
XNCRXencor IncDahiyat Bassil IPres, CEOS - Sale+OE$40.51-50,000343,067-13%-$2,025,690
D
2018-06-15
RAREUltragenyx Pharmaceutical Inc.Huizenga Theodore AlanVP, Controller, PAOS - Sale+OE$83.70-95511,940-7%-$79,934
DM
2018-06-12
PKTXProtokinetix, Inc.Smith Clarence EdwardPres, CEO, 10%P - Purchase$0.10+448,50062,579,542+1%+$43,510
2018-06-15
ATNMActinium Pharmaceuticals, Inc.O'Loughlin StevePrincipal Financial OfficerP - Purchase$0.50+12,00025,500+89%+$6,000
D
2018-06-13
XNCRXencor IncKuch John JSVP, CFOS - Sale+OE$41.64-25,00092,482-21%-$1,040,945
2017-11-17
MYOVMyovant Sciences Ltd.Altmeyer MarkDirP - Purchase$13.38+3,5003,500New+$46,830
2018-06-14
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$59.20-3,422147,469-2%-$202,582
DM
2018-06-13
FGENFibrogen IncCotroneo PatSVP, Finance, CFOS - Sale+OE$59.47-10,069224,704-4%-$598,806
2018-06-14
EOLSEvolus, Inc.Malik VikramDirP - Purchase$28.88+8,6008,600New+$248,353
D
2018-06-13
ARRYArray Biopharma IncSandor VictorChief Medical OfficerS - Sale+OE$18.75-22,424210,086-10%-$420,450
D
2018-06-13
GALTGalectin Therapeutics IncTraber Peter GPres, CEOS - Sale+OE$7.51-100,000107,333-48%-$751,000
D
2018-06-14
LCILannett Co IncSmith KevinSVP of SalesS - Sale+OE$16.51-11,66718,458-39%-$192,622
2018-06-14
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$86.31-107,698122,230,8040%-$9,295,414
2018-06-14
TNXPTonix Pharmaceuticals Holding Corp.Sullivan Gregory MChief Medical OfficerP - Purchase$3.96+10,00020,482+95%+$39,650
M
2018-06-12
ALBOAlbireo Pharma, Inc.Mattsson JanCOOS - Sale$32.26-25,00034,214-42%-$806,509
2018-06-13
GALTGalectin Therapeutics Inc10X Fund, L.P.10%S - Sale$7.17-208,1402,801,646-7%-$1,493,276
A
2018-06-08
GALTGalectin Therapeutics IncCzirr James CDirS - Sale$5.88-110,0003,009,786-4%-$646,800
2018-06-13
GALTGalectin Therapeutics IncCzirr James CDirS - Sale$7.17-208,1402,801,646-7%-$1,493,276
D
2018-05-16
SNBPSun Biopharma, Inc.Kaysen David BPres, CEOP - Purchase$0.00+1,00051,000+2%+$0
D
2018-05-16
SNBPSun Biopharma, Inc.Schaffer Paul W.DirP - Purchase$0.00+5,0001,100,0520%+$0
2018-06-12
ALRNAileron Therapeutics IncApple Tree Partners II LP10%S - Sale$5.40-10,8431,502,677-1%-$58,558
D
2018-06-12
GALTGalectin Therapeutics IncCallicutt Jack WCFOS - Sale+OE$7.01-9,2941,260-88%-$65,167
DM
2018-06-12
GALTGalectin Therapeutics IncShlevin Harold H.COOS - Sale+OE$7.41-43,6980-100%-$323,986
D
2018-06-12
AGIOAgios Pharmaceuticals IncBowden ChristopherChief Medical OfficerS - Sale+OE$92.89-2,000881-69%-$185,786
D
2018-06-12
TSROTesaro, Inc.Alleva Lawrence MDirS - Sale+OE$43.11-7,14229,902-19%-$307,920
2018-06-14
LLYLilly Eli & CoSkovronsky DanielSVP, CSO,, Pres LRLP - Purchase$86.22+10,00055,199+22%+$862,200
2018-06-13
AIMTAimmune Therapeutics, Inc.Bjerkholt EricCFOP - Purchase$30.41+1,60019,485+9%+$48,663
2018-06-12
TNXPTonix Pharmaceuticals Holding Corp.Lederman SethCEOP - Purchase$4.37+3,000120,393+3%+$13,110
2018-06-14
TNXPTonix Pharmaceuticals Holding Corp.Saenger BradleyCFOP - Purchase$4.10+3003,079+11%+$1,230
2018-06-14
TNXPTonix Pharmaceuticals Holding Corp.Morris Jessica EdgarCOOP - Purchase$4.19+3001,638+22%+$1,257
M
2018-06-06
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.04+8,00025,155,2890%+$306
2018-06-13
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$86.27-11,104122,338,5020%-$957,953
2018-06-12
CMRXChimerix IncBerrey M MichellePres, CEOP - Purchase$4.50+10,000424,941+2%+$45,015
DM
2018-06-11
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale+OE$46.44-30,00030,000-50%-$1,393,200
DM
2018-06-11
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale+OE$46.44-30,00030,000-50%-$1,393,200
D
2018-06-12
ZGNXZogenix, Inc.Farfel Gail MEVP, Chief Development OfficerS - Sale+OE$45.00-5,1187,143-42%-$230,310
2018-06-12
ALKSAlkermes Plc.Frates James MSVP, Alks Inc; CFO ALKSS - Sale$50.00-16,842183,438-8%-$842,179
2018-06-11
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$90.31-1,43650,135-3%-$129,685
2018-06-13
RAREUltragenyx Pharmaceutical Inc.Huizenga Theodore AlanVP, Controller, PAOS - Sale$76.97-1,3389,940-12%-$102,986
2018-06-11
AKAOAchaogen IncSchilke TobinCFOS - Sale$11.95-2,08747,186-4%-$24,940
2018-06-12
COLLCollegium Pharmaceutical, IncFleming Alison BCTOS - Sale$27.00-4,09653,362-7%-$110,592

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top